0 CHECKOUT

Zambia Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3511173
  • December 2015
  • Region: Zambia
  • 52 pages
  • Business Monitor International
1 of 3

Zambia's budget deficit will increase in 2016 thanks to another fall in copper production and the Zambian kwacha will continue its trend of depreciation on the basis of a weak copper industry outlook.

Private and government consumption will remain the key drivers of growth, with resilient domestic demand helping to offset weaknesses in the export sector. Growth will also be supported by a stable inflationary environment.

Headline Expenditure Forecast
- Pharmaceuticals: ZMW1.48bn (USD241mn) in 2014 to ZMW1.67bn (USD182mn) in 2015; +12.7% in local currency terms and -24.5% in US dollar terms. Forecast in US dollar terms decreased compared to the previous quarter.

- Healthcare: ZMW8.32bn (USD1.35bn) in 2014 to ZMW9.18bn (USD1.0bn) in 2015; +10.4% in local currency terms and -26.0% in US dollar terms. Forecast decreased compared to the previous quarter.

Note: Product cover images may vary from those shown
2 of 3

Table: Headline Pharmaceuticals & Healthcare Forecasts (Zambia 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Zambia 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Zambia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Zambia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Zambia 2011-2019)

Industry Risk Reward Ratings

Middle East and Africa Risk/Reward Index - Q1 2016

Zambia Risk/Reward Index

Rewards

Risks

Regulatory Review

Market Overview

Healthcare Sector

Epidemiology

Demographic Forecast
Table: Population Headline Indicators (Zambia 1990-2025)
Table: Key Population Ratios (Zambia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Zambia 1990-2025)
Table: Population By Age Group (Zambia 1990-2025)
Table: Population By Age Group % (Zambia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S